Supratherapeutic Tacrolimus Concentrations With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients Requiring Hospitalization: A Case Series Using Rifampin for Reversal

被引：22

作者：

Rose, Dusten T. ^{[1
,2
]}

Gandhi, Saurin M. ^{[3
]}

Bedard, Rachael A. ^{[1
,4
]}

Mondy, Kristin E. ^{[5
]}

Chu, Alexander L. ^{[6
]}

Gamble, Kelly C. ^{[1
]}

Gee, Amanda T. ^{[1
]}

Kundra, Monica A. ^{[3
]}

Williams, Amber L. ^{[1
]}

Lee, Brian K. ^{[4
,7
]}

机构：

[1] Univ Texas Austin, Dept Pharm, Dell Seton Med, Ascension Seton, Austin, TX 78701 USA

[2] Univ Texas Austin, Coll Pharm, Austin, TX 78701 USA

[3] Univ Texas Austin, Dell Med Sch, Dept Internal Med, Austin, TX 78701 USA

[4] Univ Texas Austin, Dell Med Sch, Kidney & Pancreas Transplant Program, Austin, TX 78701 USA

[5] Univ Texas Austin, Dell Med Sch, Dept Internal Med, Div Infect Dis, Austin, TX 78701 USA

[6] Univ Texas Austin, Dell Med Sch, Dept Med Educ, Austin, TX 78701 USA

[7] Univ Texas Austin, Dell Seton Med Ctr, Dept Internal Med, Div Nephrol, Austin, TX 78701 USA

来源：

OPEN FORUM INFECTIOUS DISEASES | 2022年 / 9卷 / 07期

关键词：

COVID-19; drug interactions; nirmatrelvir; ritonavir; tacrolimus; DRUG-INTERACTIONS; PHARMACOKINETICS;

D O I：

10.1093/ofid/ofac238

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Nirmatrelvir/ritonavir was recently granted emergency use authorization for mild to moderate coronavirus disease 2019. Drug-drug interactions between ritonavir and tacrolimus are underappreciated by nontransplant providers. We describe 2 solid organ transplant recipients prescribed nirmatrelvir/ritonavir for outpatient use who developed tacrolimus toxicity requiring hospitalization and were managed with rifampin for toxicity reversal.

引用

页数：5

共 50 条

[1] Case report: Supratherapeutic tacrolimus concentrations with nirmatrelvir/ritonavir in a lung transplant patient: a case report using Rifampin for reversal
Xiong, Yu
Wang, Xiaoxing
Li, Shu
Zhang, Qian
Guo, Lijuan
Chen, Wenhui
Zhao, Zhixia
Liu, Lihong
FRONTIERS IN PHARMACOLOGY, 2023, 14
[2] Nirmatrelvir/ritonavir Use With Tacrolimus in Lung Transplant Recipients: A Single-center Case Series
Dewey, Katherine W. W.
Yen, Bo
Lazo, Jose
Seijo, Leslie
Jariwala, Ripal
Shah, Rupal J. J.
Quan, David
Carpenter, Bethanne
Singer, Jonathan Paul
Breen, Karen
Hays, Steven
Florez, Rebecca
TRANSPLANTATION, 2023, 107 (05) : 1200 - 1205
[3] Influence of ensitrelvir or nirmatrelvir/ritonavir on tacrolimus clearance in kidney transplant recipients: a single-center case series
Naganawa, Hanako
Katada, Yoshiki
Nakagawa, Shunsaku
Umemura, Keisuke
Ishimura, Hiroki
Kajiwara, Moto
Endo, Hiroki
Sugimoto, Mitsuhiro
Katsube, Yurie
Kotani, Kinuka
Ohta, Saki
Hira, Daiki
Tsuda, Masahiro
Kita, Yuki
Kobayashi, Takashi
Terada, Tomohiro
JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2024, 10 (01):
[4] Effectiveness and Feasibility of Using Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients with Mild Covid-19
Agarwal, N.
Lange, N. W.
Hedvat, J.
Pereira, M.
Brown, R.
Salerno, D. M.
AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S505 - S506
[5] Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series
Cordero, Carlos Guzman
Saez-Torres de Vicente, Maria
EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2024, 31 (02) : 175 - 177
[6] Early Clinical Experience with Nirmatrelvir/Ritonavir for Treatment of COVID-19 in Solid Organ Transplant Recipients
Salerno, D.
Jennings, D.
Lange, N.
Kovac, D.
Shertel, T.
Chen, J.
Hedvat, J.
Scheffert, J.
Brown, R. S.
Pereira, M.
AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 602 - 602
[7] Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID-19 in solid organ transplant recipients
Salerno, David M.
Jennings, Douglas L.
Lange, Nicholas W.
Kovac, Danielle
Shertel, Tara
Chen, Justin K.
Hedvat, Jessica
Scheffert, Jenna
Brown, Robert S., Jr.
Pereira, Marcus R.
AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (08) : 2083 - 2088
[8] Correspondence on 'Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series'
Zhou, Xiaohua Xiao
Ji, Hong Jian
EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2024, 31 (02) : 178 - 179
[9] Phenytoin enzyme induction for management of supratherapeutic tacrolimus levels due to drug-drug interaction with nirmatrelvir/ritonavir: Case series and discussion
Marsh, Jennifer
Logan, Angela T.
Bilgili, Erin P.
Bowman, Lyndsey J.
Webb, Allyssa R.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2024, 81 (13) : e345 - e352
[10] Paxlovid (Nirmatrelvir/Ritonavir)-Induced Tacrolimus Toxicity in Organ Transplant Recipients - A Review on Drug Interactions Involving CYP3A Enzymes
Maideen, Naina Mohamed Pakkir
Al Rashid, Sulthan
CURRENT DRUG SAFETY, 2024,

← 1 2 3 4 5 →